Open Label - Personalized Therapeutic Neuromodulation for Anhedonic Depression (NCT06052137)

🧪 Interventions in This Study

• Active TBS-DLPFC (DEVICE)
• TBS-DMPFC (DEVICE)

Full eligibility criteria are available on the official NIH protocol. View the criteria ↗

📍 All Participating Trial Locations (1 Sites)

• Stanford University — Stanford, California

💰 Cost, Insurance & Patient Rights

• 100% Free Items: The investigational treatment and protocol-required procedures are supplied at zero cost by the sponsor.
• Routine Patient Care: Under federal law (ACA § 2709) and many state statutes, routine care costs are covered during participation.
• Voluntary Participation: You may withdraw at any time without affecting your standard medical care.

More studies in Treatment Resistant Depression

• Deep Brain Stimulation for Treatment Resistant Depression With the Medtronic Activa PC+S — Atlanta, Georgia
• Specialized Pro-resolving Lipid Mediators and Treatment Resistant Depression — Atlanta, Georgia
• An Open Label Study of the Safety and Efficacy of Psilocybin in Participants With Treatment-Resistant Depression (P-TRD) — Palo Alto, California
• Rapid Acting Transcranial Magnetic Stimulation — Stanford, California
• Transcranial Direct Current Stimulation (tDCS) as an Adjunctive Treatment for Treatment Resistant Depression (TRD) — Rochester, Minnesota

Explore by condition: All Treatment Resistant Depression clinical trials

💡 How to Participate

1. Check the checklist above to see if you may qualify.
2. Review the official NIH record below to find the coordinating site.
3. Ask about the visit schedule, what is covered at no cost, and any travel support.
4. Confirm with your own doctor before making a decision.